Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: A case-matched comparison

European Journal of Surgical Oncology

Volumn 36, Issue 7, 2010, Pages 691-698

  Kim, H S ^a   Han, K H ^a   Chung, H H ^a   Kim, J W ^a   Park, N H ^a   Song, Y S ^a,b   Kang, S B ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Adenomyosis; Leiomyoma; Neutrophil to lymphocyte ratio; Serum CA 125 levels; Uterine sarcomas

Indexed keywords

CA 125 ANTIGEN;

ADENOMYOSIS; ADULT; ARTICLE; BODY MASS; CANCER GROWTH; CARCINOSARCOMA; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENDOMETRIAL STROMAL TUMOR; FEMALE; HUMAN; LEIOMYOSARCOMA; LYMPHOCYTE; MAJOR CLINICAL STUDY; NEUTROPHIL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UTERUS SARCOMA;

ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CARCINOSARCOMA; CASE-CONTROL STUDIES; ENDOMETRIOSIS; FEMALE; HUMANS; LEIOMYOMA; LEIOMYOSARCOMA; LYMPHOCYTES; MIDDLE AGED; NEUTROPHILS; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; RESEARCH DESIGN; RETROSPECTIVE STUDIES; ROC CURVE; SAMPLE SIZE; SARCOMA; SARCOMA, ENDOMETRIAL STROMAL; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 77953912251     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.05.004     Document Type: Article

References (30)

1. Ryu H.S. Contemporary clinical trials in uterine corpus malignancies. J Gynecol Oncol 50 (2007) 1299-1307
2. Brooks S.E., Zhan M., Cote T., and Baquet C.R. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 93 (2004) 204-208
3. D'Angelo E., and Prat J. Uterine sarcomas: a review. Gynecol Oncol 116 (2010) 131-139
4. World Health Organization classification of tumours. In: Tavassoli F.A., and Devilee P. (Eds). Pathology and genetics of tumours of the breast and female genital organs (2003), IARC Press, Lyon
5. Wang X., Khoo U.S., Xue W.C., and Cheung A.N. Cervical and peritoneal fluid cytology of uterine sarcomas. Acta Cytol 46 (2002) 465-469
6. Tanaka Y.O., Nishida M., Tsunoda H., Okamoto Y., and Yoshikawa H. Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings. J Magn Reson Imaging 20 (2004) 998-1007
7. Sagae S., Yamashita K., Ishioka S., et al. Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan. Oncology 67 (2004) 33-39
8. Duk J.M., Bouma J., Burger G.T., Nap M., and De Bruijin H.W. CA-125 in serum and tumor from patients with uterine sarcoma. Int J Gynecol Cancer 4 (1994) 156-160
9. Huang G.S., Chiu L.G., Gebb J.S., et al. Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma. Gynecol Oncol 107 (2007) 513-517
10. Hoskins P.J., and Le N. Preoperative tumor markers at diagnosis in women with malignant mixed mullerian tumors/carcinosarcoma of the uterus. Int J Gynecol Cancer 18 (2008) 1200-1201
11. Shan W., Yang G., and Liu J. The inflammatory network: bridging senescent stroma and epithelial tumorigenesis. Front Biosci 14 (2009) 4044-4057
12. Den Ouden M., Ubachs J.M., Stoot J.E., and Van Wersch J.W. Whole blood cell counts and leucocyte differentials in patients with benign or malignant ovarian tumours. Eur J Obstet Gynecol Reprod Biol 72 (1997) 73-77
13. Jilma B., Blann A., Pernerstorfer T., et al. Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med 159 (1999) 857-863
14. Cho H., Hur H.W., Kim S.W., et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 58 (2009) 15-23
15. Walsh S.R., Cook E.J., Goulder F., Justin T.A., and Keeling N.J. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91 (2005) 181-184
16. Herishanu Y., Rogowski O., Polliack A., and Marilus R. Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol 76 (2006) 516-520
17. Olivares M., Hertrampf E., Wegner D., Capurro M.T., Letelier A., and Valenzuela E. Normal values of the hemogram and other hematological variables in subjects over 60 years old. Rev Med Chil 122 (2006) 1289-1293
18. Ruka W., Rutkowski P., Kaminska J., Rysinska A., and Steffen J. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance. Ann Oncol 12 (2001) 1423-1432
19. World Health Organization. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
20. Kawamura N., Ichimura T., Ito F., et al. Transcervical needle biopsy for the differential diagnosis between uterine sarcoma and leiomyoma. Cancer 94 (2002) 1713-1720
21. Tsujimura A., Kawamura N., Ichimura T., Honda K., Ishiko O., and Ogita S. Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas. Int J Oncol 20 (2002) 361-365
22. Blake-Mortimer J.S., Sephton S.E., Carlson R.W., Stites D., and Spiegel D. Cytotoxic T lymphocyte count and survival time in women with metastatic breast cancer. Breast J 10 (2004) 195-199
23. Anthony H.M. Blood basophils in lung cancer. Br J Cancer 45 (1982) 209-216
24. Lin E.Y., and Pollard J.W. Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 90 (2004) 2053-2058
25. Patsner B., and Mann W.J. Use of serum CA-125 in monitoring patients with uterine sarcoma. A preliminary report. Cancer 62 (1988) 1355-1358
26. Ray-Coquard I., Cropet C., Van Glabbeke M., et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 69 (2009) 5383-5391
27. Nordal R.R., Kristensen G.B., Kaern J., et al. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma. Acta Oncol 34 (1995) 797-802
28. Wolfson A.H., Woldson D.J., Sittler S.Y., et al. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas. Gynecol Oncol 42 (1994) 56-62
29. Park J.Y., Kim E.N., Kim D.Y., et al. Role of PET or PET/CT in the post-therapy surveillance of uterine sarcoma. Gynecol Oncol 109 (2008) 255-262
30. McMillan D.C. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12 (2009) 223-226